Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 74 (0%) Sep 4
At Loss
P/B:
8.21
Market Cap:
€ 6.75B ($ 7.83B)
Enterprise V:
€ 5.89B ($ 6.84B)
Volume:
23.00
Avg Vol (2M):
125.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (FRA:3920) Operating Data Charts